Clinical Characteristics and Risk Factors of Lung Cancer-Associated Acute Ischemic Stroke

Table 1

Basic information of patients in the LCA-AIS group and simple lung cancer group.

	LCA-AIS group	Simple lung cancer group	value
Male	29 (63.04%)	25 (54.38%)	0.397
Average age	65.80 ± 11.75	65.59 ± 11.73	0.133
Smoke	7 (15.22%)	11 (23.91%)	0.293
Hypertension	0 (0%)	3 (6.52%)	0.242
Diabetes	0 (0%)	2 (4.35%)	0.495
Coronary heart disease	0 (0%)	3 (6.52%)	0.242
Atrial fibrillation	0 (0%)	1 (2.17%)	1.000
Lung cancer pathology
Adenocarcinoma	32 (69.56%)	34 (73.91%)	0.886
Squamous cell carcinoma	12 (26.08%)	10 (21.73%)
Small-cell lung cancer	2 (4.34%)	2 (4.34%)
Adenocarcinoma
Poorly differentiated	24 (52.17%)	25 (54.34%)	0.861
Moderately differentiated	7 (15.21%)	7 (15.21%)
Highly differentiated	1 (2.17%)	2 (4.34%)
Squamous cell carcinoma
Poorly differentiated	12 (26.08%)	9 (19.56%)	0.455
Moderately differentiated	0 (0%)	1 (2.17%)
Highly differentiated	0 (0%)	0 (0%)
Lung cancer staging
I	3 (6.52%)	4 (8.69%)	0.978
II	3 (6.52%)	3 (6.52%)
III	3 (6.52%)	5 (10.86%)
IV	35 (76.08%)	32 (69.56%)
Limit period
(small-cell lung cancer)	1 (2.17%)	1 (2.17%)
Extensive period
(small-cell lung cancer)	1 (2.17%)	1 (2.17%)